PAP
ELV icon

Persistent Asset Partners’s Elevance Health ELV Stock Holding History

Persistent Asset Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32K Buy
+6
New +$2.23K ﹤0.01% 787
2026
Q1 		– Sell
-23,039
Closed -$8.08M – 375
2025
Q4 		$8.08M Buy
23,039
+15,233
+195% +$5.15M 3.63% 3
2025
Q3 		$2.52M Buy
+7,806
New +$2.43M 1.73% 12

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Persistent Asset Partners's ELV Position: Q2 2026 in Review

Persistent Asset Partners opened a new position in Elevance Health (ELV) in Q2 2026: 6 shares worth $2.32K. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in ELV as recently as Q4 2025.

Persistent Asset Partners first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.08M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Persistent Asset Partners held 6 shares of Elevance Health worth $2.32K as of Q2 2026.
  • Elevance Health was a new Persistent Asset Partners position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Persistent Asset Partners's portfolio in Q2 2026, its #787 holding.
  • Persistent Asset Partners first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Elevance Health position peaked at $8.08M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.